High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study (Q40587278)
Jump to navigation
Jump to search
scientific article published on February 2002
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study |
scientific article published on February 2002 |
Statements
1 reference
High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support. Results of a pilot study (English)
1 reference
Stefan Gratz
1 reference
Thomas M Behr
1 reference
Martin Béhé
1 reference
Frank Griesinger
1 reference
Joachim Riggert
1 reference
Cornelia C Kaufmann
1 reference
Bernhard Wörmann
1 reference
Gerhard Brittinger
1 reference
Wolfgang Becker
1 reference
1 February 2002
1 reference
1 reference
94
1 reference
4 Suppl
1 reference
1363-1372
1 reference
Identifiers
1 reference
1 reference